SCHEMBL9933382

SCHEMBL9933382

COc1ccc(C2(c3ccc(OC)cc3)C=Cc3c4c(c5cc(F)cc(F)c5c3O2)-c2ccccc2C4(C)C)cc1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9934203 0.93 TP53 (0.32)
SCHEMBL9934587 0.91 TP53 (0.31)
SCHEMBL9934470 0.89 PDK2 (0.32)
SCHEMBL9934164 0.89 PDE4D (0.32)
SCHEMBL9932985 0.89 KDM4E (0.31)
SCHEMBL9933979 0.86 TP53 (0.31)
SCHEMBL9935187 0.86 ALK (0.32)
SCHEMBL9934040 0.85 HTR6 (0.31) PGR
SCHEMBL25604114 0.85 PGR (0.32) PGR
SCHEMBL9932623 0.85 KDM4E (0.36) PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073838-B2 Method of making indeno-fused naphthol materials TRANSITIONS OPTICAL, INC. (US) 2015-07-07 US disclosed
US-9073838-B2 Method of making indeno-fused naphthol materials TRANSITIONS OPTICAL, INC. (US) 2015-07-07 US disclosed
US-9073838-B2 Method of making indeno-fused naphthol materials TRANSITIONS OPTICAL, INC. (US) 2015-07-07 US disclosed
US-20140364618-A1 Method of Making Indeno-Fused Naphthol Materials TRANSITIONS OPTICALS, INC. (US) 2014-12-11 US disclosed
US-20140364618-A1 Method of Making Indeno-Fused Naphthol Materials TRANSITIONS OPTICALS, INC. (US) 2014-12-11 US disclosed
US-20140364618-A1 Method of Making Indeno-Fused Naphthol Materials TRANSITIONS OPTICALS, INC. (US) 2014-12-11 US disclosed
US-8765978-B2 Method of making indeno-fused naphthol materials TRANSITIONS OPTICAL, INC. (US) 2014-07-01 US disclosed
US-20120157696-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 US disclosed
WO-2012082837-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 WO disclosed
US-20120157696-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 US disclosed
WO-2012082837-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 WO disclosed
US-20120157696-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364618-A1 Method of Making Indeno-Fused Naphthol Materials IDH3A, NQO1, IDH3B PGR 128/4885
US-20120157696-A1 METHOD OF MAKING INDENO-FUSED NAPHTHOL MATERIALS NQO1, IDH3A, IDH2 PGR 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.